Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for MDV3100

2 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCURO1450

    08/13/2014

    PROSPER: A Multinational, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Enzalutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer

    Treatment

    VICCBRE1430

    08/12/2014

    A Phase 2, Multicenter, Open-label Study to Assess the Efficacy and Safety of Enzalutamide with Trastuzumab in Subjects with HER2+ AR+ Metastatic or Locally Advanced Breast Cancer


    Print this page for your doctor